India · Delayed Price · Currency is INR Hamps Bio Statistics
Total Valuation
Hamps Bio has a market cap or net worth of INR 225.64 million. The enterprise value is 292.77 million.
| Market Cap | 225.64M |
| Enterprise Value | 292.77M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Hamps Bio has 8.71 million shares outstanding.
| Current Share Class | 8.71M |
| Shares Outstanding | 8.71M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -4.02% |
| Owned by Insiders (%) | 75.85% |
| Owned by Institutions (%) | n/a |
| Float | 2.10M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.66 |
| PB Ratio | 2.79 |
| P/TBV Ratio | 3.24 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.45 |
| EV / EBITDA | 99.79 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.85.
| Current Ratio | 1.46 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.85 |
| Debt / EBITDA | 23.46 |
| Debt / FCF | -1.18 |
| Interest Coverage | -2.20 |
Financial Efficiency
Return on equity (ROE) is -8.74% and return on invested capital (ROIC) is -3.45%.
| Return on Equity (ROE) | -8.74% |
| Return on Assets (ROA) | -2.22% |
| Return on Invested Capital (ROIC) | -3.45% |
| Return on Capital Employed (ROCE) | -4.15% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.66M |
| Profits Per Employee | -144,843 |
| Employee Count | 51 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.34 |
Taxes
In the past 12 months, Hamps Bio has paid 388,000 in taxes.
| Income Tax | 388,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.21% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -10.21% |
| 50-Day Moving Average | 25.25 |
| 200-Day Moving Average | 22.99 |
| Relative Strength Index (RSI) | 54.59 |
| Average Volume (20 Days) | 8,400 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Hamps Bio had revenue of INR 84.75 million and -7.39 million in losses. Loss per share was -0.85.
| Revenue | 84.75M |
| Gross Profit | 51.40M |
| Operating Income | -5.11M |
| Pretax Income | -7.00M |
| Net Income | -7.39M |
| EBITDA | 2.93M |
| EBIT | -5.11M |
| Loss Per Share | -0.85 |
Balance Sheet
The company has 1.70 million in cash and 68.83 million in debt, with a net cash position of -67.13 million or -7.71 per share.
| Cash & Cash Equivalents | 1.70M |
| Total Debt | 68.83M |
| Net Cash | -67.13M |
| Net Cash Per Share | -7.71 |
| Equity (Book Value) | 81.01M |
| Book Value Per Share | 9.30 |
| Working Capital | 16.80M |
Cash Flow
In the last 12 months, operating cash flow was -7.13 million and capital expenditures -51.33 million, giving a free cash flow of -58.46 million.
| Operating Cash Flow | -7.13M |
| Capital Expenditures | -51.33M |
| Depreciation & Amortization | 8.04M |
| Net Borrowing | 39.15M |
| Free Cash Flow | -58.46M |
| FCF Per Share | -6.71 |
Margins
Gross margin is 60.65%, with operating and profit margins of -6.03% and -8.72%.
| Gross Margin | 60.65% |
| Operating Margin | -6.03% |
| Pretax Margin | -8.26% |
| Profit Margin | -8.72% |
| EBITDA Margin | 3.46% |
| EBIT Margin | -6.03% |
| FCF Margin | n/a |
Dividends & Yields
Hamps Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.27% |
| FCF Yield | -25.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 8, 2025. It was a forward split with a ratio of 2.
| Last Split Date | Sep 8, 2025 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Hamps Bio has an Altman Z-Score of 1.98 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.98 |
| Piotroski F-Score | 1 |